KR960023035A - 케이엔알(knr)4 유전자를 불활성화시킴으로써 세포벽을 약화시킨 돌연변이 효모 및 그를 이용한 재조합 단백질의 생산 방법 - Google Patents

케이엔알(knr)4 유전자를 불활성화시킴으로써 세포벽을 약화시킨 돌연변이 효모 및 그를 이용한 재조합 단백질의 생산 방법 Download PDF

Info

Publication number
KR960023035A
KR960023035A KR1019940034086A KR19940034086A KR960023035A KR 960023035 A KR960023035 A KR 960023035A KR 1019940034086 A KR1019940034086 A KR 1019940034086A KR 19940034086 A KR19940034086 A KR 19940034086A KR 960023035 A KR960023035 A KR 960023035A
Authority
KR
South Korea
Prior art keywords
gene
knr4
recombinant protein
mutant yeast
yeast
Prior art date
Application number
KR1019940034086A
Other languages
English (en)
Other versions
KR0140306B1 (ko
Inventor
송영호
김창환
박기원
오영훈
김세훈
이태호
Original Assignee
성재갑
주식회사 Lg 화학
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 성재갑, 주식회사 Lg 화학 filed Critical 성재갑
Priority to KR1019940034086A priority Critical patent/KR0140306B1/ko
Publication of KR960023035A publication Critical patent/KR960023035A/ko
Application granted granted Critical
Publication of KR0140306B1 publication Critical patent/KR0140306B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/395Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

본 발명은 분자생물학적 1단계 유전자 파괴법(one step gene disruption method)으로 효모 게놈 DNA 상의 knr4 유전자를 불활성화시킴으로써 세포벽을 약화시킨 돌연변이 효모와 이를 이용한 유용 재조합 단백질의 개선된 생산 방법에 관한 것이다.

Description

케이엔알(knr)4 유전자를 불활성화시킴으로써 세포벽을 약화시킨 돌연변이 효모 및 그를 이용한 재조합 단백질의 생산 방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (6)

1단계 유전자 파괴법(one step gene disruption method)에 의해 knr4 유전자를 불활성화시킨 세포벽이 약화된 돌연변이 효모.
제1항에 있어서, ura3 유전자의 삽입에 의해 knr4 유전자를 불활성화시킨 돌연변이 효모.
제2항에 있어서, 플라스미드 pUC18-knr4-ura3를 사용하여 knr4 유전자를 불활성시킨 돌연변이 효모.
제1항에 있어서, 효모 사카로마이세스 세레비지애 EGY48의 knr4 유전자를 불활성화시킨 돌연변이 효모.
제4항에 있어서, 사카로마이세스 세레비지애 MI01(KCTC 0134BP).
제1항 내지 제5항 중 어느 한 항의 효모를 목적으로 재조합 단백질을 코드하는 유전자를 포함하는 벡터로 형질전환시킨 후 적당한 배지상에서 배양하여 상기 유전자를 발현시킨 다음, 상기 목적 재조합 단백질을 분리 및 정제함을 포함하는 재조합 단백질의 개선된 생산 방법.
※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019940034086A 1994-12-14 1994-12-14 케이엔알4 유전자를 불활성화시킴으로써 세포벽을 약화시킨 돌연변이 효모 및 그를 이용한 재조합 단백질의 생산 방법 KR0140306B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019940034086A KR0140306B1 (ko) 1994-12-14 1994-12-14 케이엔알4 유전자를 불활성화시킴으로써 세포벽을 약화시킨 돌연변이 효모 및 그를 이용한 재조합 단백질의 생산 방법

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019940034086A KR0140306B1 (ko) 1994-12-14 1994-12-14 케이엔알4 유전자를 불활성화시킴으로써 세포벽을 약화시킨 돌연변이 효모 및 그를 이용한 재조합 단백질의 생산 방법

Publications (2)

Publication Number Publication Date
KR960023035A true KR960023035A (ko) 1996-07-18
KR0140306B1 KR0140306B1 (ko) 1998-06-15

Family

ID=19401366

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940034086A KR0140306B1 (ko) 1994-12-14 1994-12-14 케이엔알4 유전자를 불활성화시킴으로써 세포벽을 약화시킨 돌연변이 효모 및 그를 이용한 재조합 단백질의 생산 방법

Country Status (1)

Country Link
KR (1) KR0140306B1 (ko)

Also Published As

Publication number Publication date
KR0140306B1 (ko) 1998-06-15

Similar Documents

Publication Publication Date Title
Sekimizu et al. Purification and preparation of antibody to RNA polymerase II stimulatory factors from Ehrlich ascites tumor cells
DE69636866D1 (en) Reverse "two-hybrid"-systeme
BR9610511B1 (pt) construções de dna, úteis em terapia genética, compreendendo ao menos uma sequência nucléica de interesse e composição farmacêutica.
EP0726317A3 (en) Bacillus-derived transglutaminase
DE69806408D1 (de) Rekombinante impfstoffe die immunogene attenuierte rpos-positiv phentotyp bakterien enthalten
CA2113712A1 (en) Papilloma virus vaccine
DE69841723D1 (de) Expression von endogenen genen durch homologe rekombination eines vektorkonstruktes mit zellulärer dna
GR3024409T3 (en) DNA sequence comprising a structural gene coding for xylose reductase or xylose reductase and xylitol dehydrogenase
EP1916304A3 (fr) Polypeptides antigéniques associés à la sclérose en plaques et utilisations
AUPN477695A0 (en) Gene therapy
KR960023035A (ko) 케이엔알(knr)4 유전자를 불활성화시킴으로써 세포벽을 약화시킨 돌연변이 효모 및 그를 이용한 재조합 단백질의 생산 방법
HUP9900750A2 (hu) Gén kifejezésére szolgáló promóterek
DK0396436T3 (da) Gærstammer til fremstilling af modne heterologe proteiner, især hirudin
KR970048454A (ko) 융합 dna 서열, 이 융합 dna 서열로부터 발현되는 융합 단백질 및 이 융합 단백질의 발현 방법
Maskell The resolution of bacteroides lipopolysaccharides by polyacrylamide gel electrophoresis
Gelfand et al. In vitro synthesis of a DNA dependent RNA polymerase coded on coliphage T7 genome.
ATE254663T1 (de) Erhöhte produktion von sekretierten proteinen durch rekombinante eukaryotische zellen
KR900014599A (ko) 본체 효모 쉬조사카로마이세스 폼베에서의 단백질 합성용 발현 벡터
AU4682685A (en) Recombinant saccharomyces
KR880007728A (ko) 비루스 벡터 및 재조합 dna
Weissenbach et al. The nucleotide sequences of two threonine tRNAs from brewer's yeast
KR880014106A (ko) 안정한 크레아틴 아미디노 가수분해효소 돌연변이체
WO2002027025A3 (en) Application of bioinformatics for direct study of unculturable microorganisms
RU2001104431A (ru) Способ получения белков в трансформированных дрожжевых клетках
Simarov et al. Nonsense-missense suppression in yeast

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20060105

Year of fee payment: 9

LAPS Lapse due to unpaid annual fee